331 related articles for article (PubMed ID: 31428936)
1. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.
Janin M; Ortiz-Barahona V; de Moura MC; Martínez-Cardús A; Llinàs-Arias P; Soler M; Nachmani D; Pelletier J; Schumann U; Calleja-Cervantes ME; Moran S; Guil S; Bueno-Costa A; Piñeyro D; Perez-Salvia M; Rosselló-Tortella M; Piqué L; Bech-Serra JJ; De La Torre C; Vidal A; Martínez-Iniesta M; Martín-Tejera JF; Villanueva A; Arias A; Cuartas I; Aransay AM; La Madrid AM; Carcaboso AM; Santa-Maria V; Mora J; Fernandez AF; Fraga MF; Aldecoa I; Pedrosa L; Graus F; Vidal N; Martínez-Soler F; Tortosa A; Carrato C; Balañá C; Boudreau MW; Hergenrother PJ; Kötter P; Entian KD; Hench J; Frank S; Mansouri S; Zadeh G; Dans PD; Orozco M; Thomas G; Blanco S; Seoane J; Preiss T; Pandolfi PP; Esteller M
Acta Neuropathol; 2019 Dec; 138(6):1053-1074. PubMed ID: 31428936
[TBL] [Abstract][Full Text] [Related]
2. NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.
Wu R; Sun C; Chen X; Yang R; Luan Y; Zhao X; Yu P; Luo R; Hou Y; Tian R; Bian S; Li Y; Dong Y; Liu Q; Dai W; Fan Z; Yan R; Pan B; Feng S; Wu J; Chen F; Yang C; Wang H; Dai H; Shu M
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2321611121. PubMed ID: 38547058
[TBL] [Abstract][Full Text] [Related]
3. RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma.
Zhou J; Kong YS; Vincent KM; Dieters-Castator D; Bukhari AB; Glubrecht D; Liu RZ; Quilty D; Findlay SD; Huang X; Xu Z; Yang RZ; Zhang L; Tang E; Lajoie G; Eisenstat DD; Gamper AM; Fahlman R; Godbout R; Postovit LM; Fu Y
Mol Oncol; 2023 Sep; 17(9):1763-1783. PubMed ID: 37057706
[TBL] [Abstract][Full Text] [Related]
4. Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth.
Heissenberger C; Liendl L; Nagelreiter F; Gonskikh Y; Yang G; Stelzer EM; Krammer TL; Micutkova L; Vogt S; Kreil DP; Sekot G; Siena E; Poser I; Harreither E; Linder A; Ehret V; Helbich TH; Grillari-Voglauer R; Jansen-Dürr P; Koš M; Polacek N; Grillari J; Schosserer M
Nucleic Acids Res; 2019 Dec; 47(22):11807-11825. PubMed ID: 31722427
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer.
Ortiz-Barahona V; Soler M; Davalos V; García-Prieto CA; Janin M; Setien F; Fernández-Rebollo I; Bech-Serra JJ; De La Torre C; Guil S; Villanueva A; Zhang PH; Yang L; Guarnacci M; Schumann U; Preiss T; Balaseviciute U; Montal R; Llovet JM; Esteller M
Mol Cancer; 2023 May; 22(1):83. PubMed ID: 37173708
[TBL] [Abstract][Full Text] [Related]
6. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.
Hua CD; Bian EB; Chen EF; Yang ZH; Tang F; Wang HL; Zhao B
Biomed Pharmacother; 2018 Oct; 106():678-685. PubMed ID: 29990858
[TBL] [Abstract][Full Text] [Related]
7. RNA-methyltransferase Nsun5 controls the maternal-to-zygotic transition by regulating maternal mRNA stability.
Ding C; Lu J; Li J; Hu X; Liu Z; Su H; Li H; Huang B
Clin Transl Med; 2022 Dec; 12(12):e1137. PubMed ID: 36495115
[TBL] [Abstract][Full Text] [Related]
8. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
9. Expression of the RNA methyltransferase Nsun5 is essential for developing cerebral cortex.
Chen P; Zhang T; Yuan Z; Shen B; Chen L
Mol Brain; 2019 Aug; 12(1):74. PubMed ID: 31462248
[TBL] [Abstract][Full Text] [Related]
10. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
Gao J; Chen T; Liu J; Liu W; Hu G; Guo X; Yin B; Gong Y; Zhao J; Qiang B; Yuan J; Peng X
Glia; 2009 Jul; 57(9):989-99. PubMed ID: 19062177
[TBL] [Abstract][Full Text] [Related]
11. Mice with NOP2/sun RNA methyltransferase 5 deficiency die before reaching puberty due to fatal kidney damage.
Zhang H; Li X; Bai J; Zhang C
Ren Fail; 2024 Dec; 46(1):2349139. PubMed ID: 38712768
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer.
Rosselló-Tortella M; Llinàs-Arias P; Sakaguchi Y; Miyauchi K; Davalos V; Setien F; Calleja-Cervantes ME; Piñeyro D; Martínez-Gómez J; Guil S; Joshi R; Villanueva A; Suzuki T; Esteller M
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20785-20793. PubMed ID: 32778592
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.
Wang Y; Wang M; Wei W; Han D; Chen X; Hu Q; Yu T; Liu N; You Y; Zhang J
Oncotarget; 2016 Aug; 7(31):49450-49458. PubMed ID: 27385092
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
15. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
16. Genomic Space of
Ibrahim Al-Obaide MA; Arutla V; Bacolod MD; Wang W; Zhang R; Srivenugopal KS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801310
[TBL] [Abstract][Full Text] [Related]
17. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
18. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
[TBL] [Abstract][Full Text] [Related]
19. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
Patel R; Shervington L; Lea R; Shervington A
Brain Res; 2008 Jan; 1188():173-81. PubMed ID: 18021753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
